| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |